Novel treatments for autistic spectrum disorders

Area of Science:

• Developmental Pediatrics
• Autism Spectrum Disorders Research

Background:

• Autistic spectrum disorders (ASD) present significant treatment controversies in developmental pediatrics.
• Complementary and alternative medical therapies (CAM) are frequently chosen by families seeking root-cause treatments for ASD.
• CAM interventions for ASD are categorized by proposed mechanisms, including immune modulation, gastrointestinal support, neurotransmitter supplements, and non-biologic approaches.

Purpose of the Study:

• To examine the rationale, evidence of efficacy, and side effects of various CAM therapies used for autism.
• To provide a critical review of CAM treatments for ASD, highlighting the need for robust clinical evidence.
• To discuss the example of secretin therapy, illustrating the rapid adoption and subsequent lack of evidence for certain ASD treatments.

Main Methods:

• Review of existing literature on CAM therapies for autism spectrum disorders.
• Analysis of proposed mechanisms of action for different CAM categories.
• Case study examination of secretin therapy for autism.

Main Results:

• Many CAM therapies for ASD lack substantiation from well-designed clinical studies.
• The proposed mechanisms for behavioral effects of some CAM therapies, like secretin, were not supported by clinical evidence.
• Evidence for the efficacy of numerous CAM interventions for ASD remains limited or absent.

Conclusions:

• Families and clinicians require access to high-quality, well-designed clinical evidence to make informed decisions about ASD therapies.
• The perceived benefits of many CAM therapies for autism are not supported by scientific validation.
• Further rigorous research is essential to guide the selection of effective and safe treatments for children with ASD.